Schrodinger (NASDAQ:SDGR) Stock Rating Lowered by Wall Street Zen

Wall Street Zen cut shares of Schrodinger (NASDAQ:SDGR) from a hold rating to a sell rating in a report issued on Saturday morning.

Several other equities analysts also recently commented on the stock. Barclays began coverage on shares of Schrodinger in a report on Thursday, August 14th. They issued an “overweight” rating and a $25.00 target price on the stock. Weiss Ratings reiterated a “sell (d-)” rating on shares of Schrodinger in a report on Saturday, September 27th. KeyCorp dropped their price objective on shares of Schrodinger from $32.00 to $30.00 and set an “overweight” rating for the company in a report on Monday, July 14th. Morgan Stanley cut their price objective on Schrodinger from $28.00 to $19.00 and set an “equal weight” rating for the company in a research report on Monday, August 18th. Finally, The Goldman Sachs Group initiated coverage on Schrodinger in a research report on Monday, September 29th. They issued a “neutral” rating and a $19.00 target price on the stock. Four analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $26.57.

Schrodinger Stock Up 3.4%

NASDAQ SDGR opened at $21.29 on Friday. Schrodinger has a twelve month low of $16.60 and a twelve month high of $28.47. The business has a 50-day moving average price of $19.59 and a 200-day moving average price of $21.38. The firm has a market cap of $1.57 billion, a price-to-earnings ratio of -8.58 and a beta of 1.74.

Schrodinger (NASDAQ:SDGR) last issued its earnings results on Wednesday, August 6th. The company reported ($0.59) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.83) by $0.24. Schrodinger had a negative return on equity of 45.70% and a negative net margin of 76.22%.The company had revenue of $54.76 million for the quarter, compared to the consensus estimate of $52.03 million. During the same quarter last year, the company earned ($0.66) EPS. The firm’s quarterly revenue was up 15.7% on a year-over-year basis. Research analysts expect that Schrodinger will post -2.37 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. GAMMA Investing LLC raised its position in Schrodinger by 4,213.0% during the 1st quarter. GAMMA Investing LLC now owns 120,592 shares of the company’s stock valued at $2,380,000 after purchasing an additional 117,796 shares in the last quarter. Harbor Capital Advisors Inc. raised its holdings in shares of Schrodinger by 32.4% in the first quarter. Harbor Capital Advisors Inc. now owns 15,005 shares of the company’s stock valued at $296,000 after acquiring an additional 3,676 shares in the last quarter. Greenwood Capital Associates LLC lifted its stake in Schrodinger by 2.7% in the first quarter. Greenwood Capital Associates LLC now owns 23,139 shares of the company’s stock worth $457,000 after acquiring an additional 612 shares during the period. Stanley Laman Group Ltd. grew its holdings in Schrodinger by 17.3% during the 1st quarter. Stanley Laman Group Ltd. now owns 186,980 shares of the company’s stock worth $3,691,000 after acquiring an additional 27,511 shares in the last quarter. Finally, Palumbo Wealth Management LLC purchased a new position in Schrodinger during the 1st quarter valued at about $345,000. Institutional investors own 79.05% of the company’s stock.

About Schrodinger

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.